130 related articles for article (PubMed ID: 6702418)
1. Immune complexes and the complement factors C4 and C3 in cerebrospinal fluid and serum from patients with chronic progressive multiple sclerosis.
Jans H; Heltberg A; Zeeberg I; Kristensen JH; Fog T; Raun NE
Acta Neurol Scand; 1984 Jan; 69(1):34-8. PubMed ID: 6702418
[TBL] [Abstract][Full Text] [Related]
2. Circulating immune complexes and complement in the course of multiple sclerosis.
Jans H; Heltberg A; Raun NE
Acta Neurol Scand; 1982 Oct; 66(4):488-96. PubMed ID: 6216715
[TBL] [Abstract][Full Text] [Related]
3. Immune complexes in schistosomiasis IV. C3, C4 and C1q characterization and correlation between C3 in serum and circulating IC levels.
Santoro F; Bout D; Camus D; Capron A
Rev Inst Med Trop Sao Paulo; 1977; 19(1):39-42. PubMed ID: 897474
[No Abstract] [Full Text] [Related]
4. Circulating immune complexes in patients with multiple sclerosis. A longitudinal study of serum and CSF by C1q and platelet binding tests.
Arnadottir T; Kekomäki R; Lund GA; Reunanen M; Salmi AA
J Neurol Sci; 1982 Sep; 55(3):273-83. PubMed ID: 6982312
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes in serum and in cerebrospinal fluid of patients with multiple sclerosis. Characterization and correlation with the clinical course.
Procaccia S; Lanzanova D; Caputo D; Ferrante P; Papini E; Gasparini A; Colucci A; Bianchi M; Villa P; Blasio R
Acta Neurol Scand; 1988 May; 77(5):373-81. PubMed ID: 3046225
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid complement proteins in neurological disease.
Price P; Cuzner ML
J Neurol Sci; 1980 Apr; 46(1):49-54. PubMed ID: 6966324
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of the complement factors C3 and C4 within the central nervous system over the course of aseptic meningitis.
Frydén A; Forsberg P; Link H
Acta Neurol Scand; 1983 Sep; 68(3):157-63. PubMed ID: 6650127
[TBL] [Abstract][Full Text] [Related]
8. Relationship between secretory IgA, IgA-containing (C3-fixing) circulating immune complexes, and complement components (C3, C4) in patients with obstructive jaundice.
Ohshio G; Furukawa F; Manabe T; Tobe T; Hamashima Y
Scand J Gastroenterol; 1986 Mar; 21(2):151-7. PubMed ID: 3715384
[TBL] [Abstract][Full Text] [Related]
9. Relationship of C3 & C4 levels with filarial immune complexes in bancroftian filariasis.
Prasad GB; Harinath BC
Indian J Med Res; 1989 Sep; 89():322-5. PubMed ID: 2697689
[TBL] [Abstract][Full Text] [Related]
10. IgA containing immune complexes in rheumatoid vasculitis and in active rheumatoid disease.
Westedt ML; Daha MR; de Vries E; Valentijn RM; Cats A
J Rheumatol; 1985 Jun; 12(3):449-55. PubMed ID: 4045842
[TBL] [Abstract][Full Text] [Related]
11. Immune complexes in serum and in cerebrospinal fluid in African trypanosomiasis. Correlation with polyclonal B cell activation and with intracerebral immunoglobulin synthesis.
Lambert PH; Berney M; Kazyumba G
J Clin Invest; 1981 Jan; 67(1):77-85. PubMed ID: 6969733
[TBL] [Abstract][Full Text] [Related]
12. [Significance of immunocomplexes and complement in renal transplantation. Preliminary data].
Schena FP; Pertosa G; Manno C; Losuriello V; Pastore A
Minerva Chir; 1980 May; 35(10):709-14. PubMed ID: 7005726
[TBL] [Abstract][Full Text] [Related]
13. Complement and sepsis.
Gutiérrez-Fernández J; Maroto MC; Piédrola G; Zamora E
Allergol Immunopathol (Madr); 1987; 15(3):145-9. PubMed ID: 3661354
[TBL] [Abstract][Full Text] [Related]
14. The determination of the complement components C1q, C4 and C3 in serum and cerebrospinal fluid by radioimmunoassay.
Dujardin BC; Driedijk PC; Roijers AF; Out TA
J Immunol Methods; 1985 Jun; 80(2):227-37. PubMed ID: 3925023
[TBL] [Abstract][Full Text] [Related]
15. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
Makinde VA; Senaldi G; Jawad AS; Berry H; Vergani D
Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
[TBL] [Abstract][Full Text] [Related]
16. Immune complexes in multiple sclerosis: relation to clinical pattern.
Patzold U; Haller P; Baruth B; Liman W; Deicher H
J Neurol; 1980; 222(4):249-60. PubMed ID: 6154784
[TBL] [Abstract][Full Text] [Related]
17. Bell's palsy: an immune complex disease.
Larsson A; Jonsson L; Sjöquist J
ORL J Otorhinolaryngol Relat Spec; 1990; 52(3):164-7. PubMed ID: 2141682
[TBL] [Abstract][Full Text] [Related]
18. [Complement components, whole complement activity, and circulating immune complexes in neoplastic diseases].
Takada K; Morishita M; Sugiura T; Suzuki M; Torii Y; Ichimura K; Hashigami H; Toshikawa K; Ina Y; Yamamoto M; Oyama A; Urata A
Gan No Rinsho; 1983 Apr; 29(4):A-19, 293-6. PubMed ID: 6602233
[TBL] [Abstract][Full Text] [Related]
19. Activation of the alternative complement pathway by unidentified substances in human glomerulonephritis.
Schena FP; Pertosa G; Vox E; Bonomo L
Nephron; 1981; 27(1):9-14. PubMed ID: 6908651
[TBL] [Abstract][Full Text] [Related]
20. [Immune complex and complement levels in spontaneous abortions and normal pregnancy].
Saitoh S; Nakanishi A; Ichijo M
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Nov; 35(11):1981-90. PubMed ID: 6607297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
